Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Raising Approval Bar For NSAID/PPI Combos; Endpoints Under Review

Nov 17 2008

• By Kate Rawson

Related Content

Pozen/AZ Combo Pill Could See Setback As FDA Reviews Trial Endpoints

Oct 17 2008

Vioxx Withdrawal Could Have Impact On Post-Marketing Surveillance Methods

Oct 04 2004

Celebrex, Vioxx GI Safety Differences May Be Indistinguishable - FDA Cmte.

Feb 12 2001

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window